Getting to the top that we aim at is hard teamwork.
Zoltan Laboratories have worked, in most cases on a contractual basis, with
several research laboratories in the U.S.A., Hungary, Germany, and France to
perform the in vitro and animal studies as well as produce highly purified and
recombinant forms of PLAP for its programs.
Zoltan Laboratories have also established a collaboration with a Minneapolis
based firm specialized in expressing human proteins in plants, to produce
recombinant PLAP from tobacco leaves. This new technology will produce
humanized PLAP at about 20 to 50-times less cost compared to recombinant
PLAP produced by human cells.